Comparing the pan Aurora kinase inhibitor R763 [25] with the Aurora-A specific inhibitor MLN our results establish Aurora-B as the potentially more powerful target in SCCHN, but cannot rule out that a combined Aurora-A and Aurora-B inhibition might be beneficial to induce mitotic failure and cell death. The gene discussed is AURKB; the disease is head and neck squamous cell carcinoma.